Stopping Deaths Caused by Antibiotic Resistance

by Phages for Global Health
Play Video
Stopping Deaths Caused by Antibiotic Resistance
Stopping Deaths Caused by Antibiotic Resistance
Stopping Deaths Caused by Antibiotic Resistance
Stopping Deaths Caused by Antibiotic Resistance
Stopping Deaths Caused by Antibiotic Resistance
Stopping Deaths Caused by Antibiotic Resistance
Stopping Deaths Caused by Antibiotic Resistance
Stopping Deaths Caused by Antibiotic Resistance
Stopping Deaths Caused by Antibiotic Resistance
Stopping Deaths Caused by Antibiotic Resistance
Stopping Deaths Caused by Antibiotic Resistance
Toilet in Haiti (credit: Dr. Minmin Yen)
Toilet in Haiti (credit: Dr. Minmin Yen)

As part of Phages for Global Health's mission to help bring phage therapy to Africa and Asia, our founder, Dr. Tobi Nagel, serves on the advisory board of PhagePro, a company that is developing a phage product to control cholera outbreaks. Cholera currently infects an estimated 3 - 5 million people per year, and cholera bacterial strains worldwide are developing antibiotic resistance at an alarming rate. However, since this is a disease that almost exclusively occurs in developing countries, few companies are willing to develop new drugs to address it.

We are excited to report that PhagePro recently won $3 million in grants from the US National Institutes of Health to further its development of cholera phages! This will enable the company to work out product formulation and manufacturing issues and prepare for a clinical trial. The trial eventually will be conducted at the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), a renowned clinical research institute that treats a high number of cholera patients. In fact, the phages in PhagePro's product were originally isolated in collaboration with colleagues at icddr,b.

At a recent international conference called Phage Futures, Dr. Nagel and PhagePro’s CEO, Dr. Minmin Yen, co-led a virtual discussion group on “Phage Therapy for Preventing and Treating Diseases in Developing Countries”. Participants from many developing and developed countries attended, and there was much enthusiasm not only for the cholera phage project, but also for other potential phage applications in developing countries. There is still much work to do, but we are excited about eventually bringing cholera phages as well as other types of phages into the clinical setting!

 - Dr. Minmin Yen took the attached photo while sampling for cholera phages in contaminated waters in Haiti, site of one of the largest cholera outbreaks in recent history -

Links:

Share on Twitter Share on Facebook
 

About Project Reports

Project Reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.

If you donate to this project or have donated to this project, you will get an e-mail when this project posts a report. You can also subscribe for reports via e-mail without donating.

Get Reports via Email

We'll only email you new reports and updates about this project.

Organization Information

Phages for Global Health

Location: Oakland, CA - USA
Website:
Project Leader:
Tobi Nagel
Oakland, CA United States
$25,993 raised of $40,000 goal
 
65 donations
$14,007 to go
Donate Now
lock
Donating through GlobalGiving is safe, secure, and easy with many payment options to choose from. View other ways to donate

Phages for Global Health has earned this recognition on GlobalGiving:

Help raise money!

Support this important cause by creating a personalized fundraising page.

Start a Fundraiser

Learn more about GlobalGiving

Teenage Science Students
Vetting +
Due Diligence

Snorkeler
Our
Impact

Woman Holding a Gift Card
Give
Gift Cards

Young Girl with a Bicycle
GlobalGiving
Guarantee

Sign up for the GlobalGiving Newsletter

WARNING: Javascript is currently disabled or is not available in your browser. GlobalGiving makes extensive use of Javascript and will not function properly with Javascript disabled. Please enable Javascript and refresh this page.